The translational landscape of mTOR signalling steers cancer initiation and metastasis
Andrew C. Hsieh(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Davide Ruggero(University of California, San Francisco), Annie Sher(University of California, San Francisco), Merritt P. Edlind(University of California, San Francisco), Michael Bonham(University of California, San Francisco), Nicholas T. Ingolia(QB3), Jonathan S. Weissman(Howard Hughes Medical Institute), Katti Jessen(Intel (United States)), Carly Christensen(University of California, San Francisco), Evan Y. Shi(University of California, San Francisco), Christian Rommel(Intel (United States)), Matthew R. Janes(University of California, Irvine), Craig R. Stumpf(University of California, San Francisco), Kevan M. Shokat(Howard Hughes Medical Institute), Shunyou Wang(Intel (United States)), Yi Liu(Shenyang University of Chemical Technology), Pingda Ren(Intel (United States)), Morris E. Feldman(Weizmann Institute of Science), Michael Martin(Intel (United States))
Cited by 1,355
Related Papers
K-Ras(G12C) inhibitors allosterically control GTP affinity and effector interactions
|Nature|2013|2.5k
Ribosome Profiling of Mouse Embryonic Stem Cells Reveals the Complexity and Dynamics of Mammalian Proteomes
|Cell|2011|2.3k
RAF inhibitors transactivate RAF dimers and ERK signalling in cells with wild-type BRAF
|Nature|2010|1.8k
Molecular Chaperones and Protein Quality Control
|Cell|2006|1.6k
IRE1 Signaling Affects Cell Fate During the Unfolded Protein Response
|Science|2007|1.4k